TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET).
Chibawanye I Ene et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.